Commentary Raises Safety Concerns Over Medical Cannabis Market Launch in England
What happened
Peter Hitchens commented on the launch of pharmaceutical-grade medical cannabis in England, questioning the risks associated with the drug. He noted that daily users of cannabis are more than three times as likely to develop psychosis compared to non-users, according to the EU-GEI study published in 2019. Hitchens also drew a comparison between the drug's risks and the historical tragedy of Thalidomide.
From dailymail.com
Why it matters
The launch involves Boots offering medical-grade cannabis on prescription in England. The commentary highlights public and regulatory concerns regarding the safety and ethical implications of introducing this drug into the market. This puts pressure on governing bodies to manage the new clinical guidelines and monitor drug risks.
From dailymail.com
Who's involved
- Peter HitchensEnglish journalist who provided commentary on the medical cannabis market launch in England
- EnglandThe location where the medical cannabis market is launching
- Department of Health and Social CareGovernment agency responsible for managing new clinical guidelines and monitoring drug risks
- parliamentLegislative body that may face pressure regarding drug risks and ethical debates
- governmentThe system governing the community, which must oversee the policy implications of the new drug market
Keep exploring
The entities involved
-
Peter Hitchens
English journalist and author (born 1951)
Nothing else this week.
-
England
country in north-west Europe, part of the United Kingdom